GLWL.F Stock Overview
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Glow Lifetech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.075 |
| 52 Week High | CA$0.083 |
| 52 Week Low | CA$0.02 |
| Beta | 2.53 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| GLWL.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | n/a | 2.5% | 1.6% |
| 1Y | n/a | 18.4% | 26.4% |
Return vs Industry: Insufficient data to determine how GLWL.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how GLWL.F performed against the US Market.
Price Volatility
| GLWL.F volatility | |
|---|---|
| GLWL.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: GLWL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GLWL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron.
Glow Lifetech Corp. Fundamentals Summary
| GLWL.F fundamental statistics | |
|---|---|
| Market cap | US$6.03m |
| Earnings (TTM) | -US$1.13m |
| Revenue (TTM) | US$142.13k |
59.4x
P/S Ratio-7.5x
P/E RatioIs GLWL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GLWL.F income statement (TTM) | |
|---|---|
| Revenue | CA$192.04k |
| Cost of Revenue | CA$79.00k |
| Gross Profit | CA$113.04k |
| Other Expenses | CA$1.63m |
| Earnings | -CA$1.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 58.86% |
| Net Profit Margin | -792.23% |
| Debt/Equity Ratio | -313.0% |
How did GLWL.F perform over the long term?
See historical performance and comparison